article = {ACR-2020-1-108}
title = {Review of Anaesthesia and Analgesia in Patients with COVID-19 in Brazil}
journal = {Anesthesia and Clinical Research}
year = {2020}
issn = {2733-2500}
doi = {http://dx.doi.org/10.31487/j.ACR.2020.01.08}
url = {https://www.sciencerepository.org/review-of-anaesthesia-and-analgesia-in-patients-with-covid-19_ACR-2020-1-108 
author = {Mônica Santos  de Melo,Júlia Ferreira  Nogueira,Lucas Vinicius  Andrade dos Santos,Luis Claudio  Bettamio de Sousa,Raiane  Nascimento Santana,Weslly Jonas  Severo da Silva,Wictor Hugo  de Souza Silva,Makson Gleydson Brito de Oliveira,}
keywords = {COVID-19, SARS-CoV-2, anaesthetics, analgesics}
abstract ={Severe acute respiratory syndrome (COVID-19), produced by SARS-CoV-2, remains a challenge for
modern medicine and a global health problem. For every 100 patients with COVID-19, about 20 need
hospital care. In addition, some patients will be intubated and others under mechanical ventilation.
Therefore, it is necessary to use drugs as a sedative and analgesic purpose, mainly. Thus, this study brings
a survey on the drugs that can be used for the management of patients with COVID-19 in cases of intubation
and mechanical ventilation in Brazil. In this paper, we will report the classes of anaesthetic and analgesic
drugs. Highlighting the clinical indications for use, pharmacological characteristics of each drug in terms of
doses, pharmacokinetics, pharmacodynamics and possible side effects and, in addition, peculiarities of drugs
related to use in patients with COVID-19, when possible.}